Biocept Inc. struck a deal with life science distributor HarlePhil Venture Inc. to get Biocept’s liquid biopsy tests into the Philippines market.
Biocept, a San Diego firm developing liquid biopsy tests for cancer, will do all diagnostic testing services under the deal, with HarlePhil taking on sales, marketing, distribution, and reimbursement of the company’s liquid biopsy platform.
"This is our first distribution agreement in Southeast Asia and marks a key milestone in our goal of expanding the distribution of our proprietary testing services into international markets," said Michael Nall, president and CEO of Biocept, in a statement.
This makes the third international distribution agreements Biocept has announced, including deals in Israel and Mexico.
Nall said that the company plans to expand into additional international markets in the future.